| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| T661624-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $218.90 |
| Specifications & Purity | 10mM in Water |
|---|---|
| Storage Temp | Desiccated,Store at -80°C |
| Shipped In | Ice chest + Ice pads |
| Product Description | TAK-960 dihydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1) , with an IC 50 of 0.8 nM. TAK-960 dihydrochloride also shows inhibitory activities against PLK2 and PLK3 , with IC 50 s of 16.9 and 50.2 nM, respectively. TA IC50& Target:PLK1 0.8 nM (IC 50 ) PLK2 16.9 nM (IC 50 ) PLK3 50.2 nM (IC 50 ) FAK/PTK2 19.6 nM (IC 50 ) MLCK/MYLK 25.6 nM (IC 50 ) FES/FPS 58.2 nM (IC 50 ) In Vitro:TAK-960 dihydrochloride treatment causes accumulation of G2-M cells, aberrant polo mitosis morphology, and increased phosphorylation of histone H3 (pHH3). TAK-960 dihydrochloride (2-1000 nM; 72 hours) inhibits proliferation of multiple cancer cell lines, In Vivo:TAK-960 dihydrochloride exhibits (10mg/kg; p.o.; once daily for 2 weeks) significant efficacy against multiple tumor xenografts. In animal models, TAK-960 dihydrochloride (p.o.) increases pHH3 in a dose-dependent manner and significantly inhibits th Biological Activity:TAK-960 dihydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1) , with an IC 50 of 0.8 nM. TAK-960 dihydrochloride also shows inhibitory activities against PLK2 and PLK3 , with IC 50 s of 16.9 and 50.2 nM, respectively. TA |
| Canonical SMILES | [H]Cl.O=C(NC1CCN(C)CC1)C2=CC(OC)=C(NC3=NC=C(N4C)C(N(C5CCCC5)CC(F)(F)C4=O)=N3)C=C2F.[H]Cl |
|---|---|
| Molecular Weight | 634.52 |
Enter Lot Number to search for COA:
